Point72 Middle East FZE’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,201
Closed -$121K 209
2023
Q4
$121K Sell
1,201
-117,619
-99% -$11.7M ﹤0.01% 1148
2023
Q3
$10.3M Buy
118,820
+90,195
+315% +$8.15M 0.34% 64
2023
Q2
$2.71M Buy
+28,625
New +$2.42M 0.08% 313
2023
Q1
Sell
-4,420
Closed -$340K 1687
2022
Q4
$340K Buy
+4,420
New +$336K 0.01% 872

Other funds holding CAH

Point72 Middle East FZE's CAH Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Cardinal Health (CAH) in Q1 2024, closing a stake of 1,201 shares — an estimated $121K sold.

Point72 Middle East FZE first reported a position in CAH in Q4 2022 and held it in 4 quarters. The position peaked at $10.3M in Q3 2023. 1,057 funds tracked by Wall St. Rank hold CAH as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Cardinal Health position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 1,201 Cardinal Health shares in Q1 2024, an estimated $121K.
  • Point72 Middle East FZE first reported a position in Cardinal Health in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's Cardinal Health position peaked at $10.3M in Q3 2023.
  • 1,057 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.